Effect of 360° VR and 2D Videos on Patient Anxiety in Outpatient Ophthalmologic Care
OpeZen
Differences Between a 360-VR Video and a 2D-video in Reducing Anxiety in an Ophtalmological Ambulatory Care Pathway
1 other identifier
interventional
180
1 country
1
Brief Summary
Background Previous research on ambulatory care pathways has highlighted recurring issues such as elevated patient anxiety, disorientation, and insufficient access to information, all of which negatively affect the patient experience. However, evidence remains limited regarding the effectiveness of different preparatory media in mitigating these issues in real-world clinical settings. Objectives The present study aims to assess whether viewing a video of an outpatient ophthalmologic care pathway prior to the day of surgery-either as a standard 2D video or as a 360° immersive video experienced in virtual reality (VR)-reduces patient anxiety and disorientation compared with a control condition without media support. In addition, the study aims to determine which medium is most effective and to explore methods for assessing anxiety, orientation, and information in ecological clinical settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 9, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 9, 2026
CompletedFirst Posted
Study publicly available on registry
April 15, 2026
CompletedApril 15, 2026
April 1, 2026
1.4 years
February 9, 2026
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients with reduced preoperative anxiety compared to baseline
The proportion of patients whose preoperative state anxiety (measured immediately before surgery using a Visual Analog Scale for Anxiety \[VAS-A\]) is lower than baseline anxiety (measured during the preoperative consultation using the VAS-A).
Baseline (preoperative consultation) and Day 1 (preoperative assessment before surgery)
Secondary Outcomes (1)
Anxiety, quality of information, and disorientation during hospitalization and the ambulatory pathway
Day 1 (postoperative assessment)
Study Arms (3)
Group Control : NON
PLACEBO COMPARATORNON (Baseline): Control condition providing no video to the patients. This is what patients really lived routinely in the ophthalmological ambulatory pathway.
Group Video : 2D-V
ACTIVE COMPARATORVideo: NON condition with the watching of a 2D video \~1month before the surgery.
Group Virtual Reality : VR
ACTIVE COMPARATORVR: NON condition with watching of a 360-VR video corresponding to a 360 video of the ophthalmological ambulatory pathway
Interventions
The control group does not view the video and receives only verbal information delivered by the administrative staff.
Before surgery, patients watch an informational video explaining the outpatient journey at IOO Jules Verne.
Eligibility Criteria
You may qualify if:
- Participants should be over 18
- Have all the cognitive and mental abilities
- Speak french
- Have a programmated ophthalmology surgery in outpatient
- Have binocular corrected visual acuity \> 5/10 (20/40 Snellen)
You may not qualify if:
- Persons referred to in Articles L.1121-6 to L.1121-8 of the French Public Health Code (CSP) (guardianship, trusteeship, legal protection, etc.)
- Patients undergoing surgery under general anesthesia
- Patients undergoing emergency surgery
- Surgery not performed within one month following the preoperative appointment (except for the control group)
- For the group participating in the VR experiment:
- \- Any medical condition preventing immersion in virtual reality (e.g., epilepsy, dizziness/vertigo, psychiatric history, use of medication or substances with psychoactive effects, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Ophtalmologique de l'Ouest Jules Vernelead
- Nantes Universitycollaborator
Study Sites (1)
Institut Ophtalmologique de l'Ouest Jules Verne
Nantes, Loire Atlantique, 44300, France
Study Officials
- PRINCIPAL INVESTIGATOR
Frank BECQUET, Docteur
Institut Ophtalmologique de l'Ouest Jules Verne
- STUDY DIRECTOR
Jean Philippe RIVIERE, Maître de conférences
Laboratoire des Sciences du Numérique de Nantes UMR-6004
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2026
First Posted
April 15, 2026
Study Start
October 1, 2024
Primary Completion
February 9, 2026
Study Completion
February 9, 2026
Last Updated
April 15, 2026
Record last verified: 2026-04